clinical trial · NCT04634812
Mass Balance Study of KBP-5074 in Healthy Male Subjects
HealthyKBP-5074
brief summary
This is a Phase 1, open-label, nonrandomized, single-dose mass balance and metabolite identification study in healthy male subjects.
started
Dec 3, 2020
primary completion
Dec 23, 2020
completion
Dec 23, 2020
last updated
Dec 16, 2025
official title
A Phase 1, Open-label, Study of the Absorption, Metabolism, and Excretion of [14C]-KBP-5074 Following a Single Oral Dose in Healthy Male Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol